Delivery Order 75N95022D00020-75N95023F00001
Award Date 9/15/23
Potential Completion Date 12/31/24
Potential Value $64K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Cape Fear, NC 28401, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $324,420.00 firm fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to PPD Development LP, a global contract research organization (CRO). The contract is for research and development services related to clinical studies in the Blueprint MedTech program, including clinical study protocol development. The contract has a 5-year period of performance from June 17, 2024 to June 16, 2029, with a base period and two option units. PPD...
- This is a $5,334 cost-plus-fixed-fee delivery order task order awarded to PPD Development LP, a global contract research organization (CRO), by the National Institute on Drug Abuse (NIDA). The task order is for the preparation of pre-submission support for a pilot participant under the Blueprint MedTech (BPMT) program, which provides CRO support for regulatory affairs. The award has an ultimate completion date of December 19, 2025, and there is no set-aside designation. PPD Development LP, a...
- This federal contract award to PPD Development LP, a global contract research organization (CRO), provides regulatory consulting assistance for a medical device developer under the Blueprint MedTech program. The $370,621 cost-plus-fixed-fee contract includes research and development for clinical studies, pre-submission assessment, and package preparation. The award is issued by the National Institute on Drug Abuse, a civilian agency, and is not set aside. PPD Development LP is a subsidiary of...
- This is a $3,358,776 cost-plus-fixed-fee Delivery Order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to PPD Development LP, a global contract research organization (CRO). The award is for a Phase I randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and pharmacokinetics of a medical product. The contract is a task order under NIDA's "Phase I Clinical Trials for Development of Neurotherapeutics" Indefinite...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, valued at $696,693.16, was awarded to PPD Development LP, a global contract research organization (CRO), to provide PPD development site and study monitoring services. The contract has no set-aside designation and is part of several indefinite delivery...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $500,263.64 Delivery Order contract to PPD Development LP, a global contract research organization (CRO), for clinical site and study monitoring services in support of research partnerships for global mental health. The contract has a period of performance from September 28, 2018 to September 27, 2023 and is a labor hours type contract. PPD Development LP has provided over $500...
- This federal contract award is for a delivery order under an Indefinite Delivery/Indefinite Quantity (ID/IQ) parent award for Phase I clinical trials for the development of neurotherapeutics. The contract, valued at $2,048,931.69, was awarded to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The work involves protocol development and finalization, database build, and bioanalytical methods development for clinical trial execution....
- This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to PPD Development LP, a global contract research organization (CRO). The contract, valued at $66,339,562.95, is for the TAS::75 0885::TAS NIAID DAIT CLINICAL SITE MONITORING CENTER and has a performance period ending on February 23, 2023. PPD Development LP, a subsidiary of Thermo Fisher...
- This is a $3,265,588.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to PPD Development LP, a global contract research organization. The contract is for a first-in-human randomized, double-blind, placebo-controlled single ascending dose (SAD) Phase I study on the development of neurotherapeutics. The contract is not set aside and is...
- This is a federal contract award to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract, valued at $139,861,060.22, is for NIAID Clinical Site Monitoring services. This is a definitive contract with a cost-plus-fixed-fee pricing type, with a period of performance through January 31, 2024. The...